ArticleBreast cancer research : BCR2018
Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment.
Nathan A Ungerleider et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
73 papers cite itlatest 60 shown
this paperpooled ittrialcites it